Pediatric Palliative Transport in Critically Ill Children: A Single Center's Experience and Parents' Perspectives

Anuradha P Menon1,2, Yee Hui Mok1,2, Lik Eng Loh1,2

  • 1Children's Intensive Care Unit, Department of Pediatric Subspecialties, KK Women's and Children's Hospital, Singapore, Singapore.

Insights

Pediatric palliative transport from intensive care units (ICUs) to home is rarely documented. Our 10-year experience and parent surveys show these critical care transports are safe and positively received, supporting end-of-life care.

Area of Science:

  • Pediatric critical care medicine
  • Palliative care
  • Transport medicine

Background:

  • Transferring critically ill children from pediatric intensive care units (PICUs) to home for palliative care is infrequently described in medical literature.
  • Limited data exists on the safety and parental satisfaction with such specialized transports.

Purpose of the Study:

  • To describe a 10-year experience with pediatric palliative transport from a PICU to home or hospice.
  • To evaluate parental perspectives on their child's transport experience.

Main Methods:

  • Retrospective review of eight pediatric palliative transports over 10 years.
  • A survey administered to parents to assess their satisfaction with the transport experience.

Main Results:

  • No adverse events occurred during any of the intratransport periods.
  • Parents reported positive experiences with the palliative transport service.
  • A dedicated critical care transport service facilitated safe palliative transfers.

Conclusions:

  • Pediatric palliative transport from the ICU to home is a safe and feasible option.
  • Facilitating home-based withdrawal of life support through specialized transport is an acceptable component of holistic end-of-life care for families.
  • Dedicated critical care transport services are essential for enabling safe palliative transfers.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
170
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
194
Continuing Care01:25

Continuing Care

Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.8K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
148
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
130
Patient-centered Care01:13

Patient-centered Care

Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
2.8K